Nurix Therapeutics Stock Forecast

Stock Price Forecast

The 13 analysts that cover Nurix Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $29.46, which forecasts a 86.34% increase in the stock price over the next year. The lowest target is $16 and the highest is $36.

Price Target: $29.46 (+86.34%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$16	$29.46	$30	$36
Change	+1.20%	+86.34%	+89.75%	+127.70%

* Price targets were last updated on Jan 29, 2026.

Analyst Ratings

The average analyst rating for Nurix Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26
Strong Buy	5	6	6	6	6	6
Buy	7	6	5	7	7	6
Hold	2	2	2	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	14	14	13	14	14	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Joseph Catanzaro Piper Sandler	Piper Sandler	Buy Maintains $32 → $35	Buy	Maintains	$32 → $35	+121.38%	Jan 29, 2026
Brian Abrahams RBC Capital	RBC Capital	Buy Maintains $28 → $30	Buy	Maintains	$28 → $30	+89.75%	Jan 29, 2026
Stephen Willey Stifel	Stifel	Strong Buy Maintains $33 → $35	Strong Buy	Maintains	$33 → $35	+121.38%	Jan 29, 2026
Derek Archila Wells Fargo	Wells Fargo	Buy Maintains $30 → $29	Buy	Maintains	$30 → $29	+83.43%	Jan 29, 2026
Jeet Mukherjee BTIG	BTIG	Strong Buy Reiterates $30	Strong Buy	Reiterates	$30	+89.75%	Jan 29, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

63.73M

from 83.98M

-24.11%

from 83.98M

Revenue Next Year

80.51M

from 63.73M

26.32%

from 63.73M

EPS This Year

-3.11

from -3.05

EPS Next Year

-2.99

from -3.11

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Nov 30, 2021	Nov 30, 2022	Nov 30, 2023	Nov 30, 2024	Nov 30, 2025	Nov 30, 2026	Nov 30, 2027
Revenue	29.75M	38.63M	76.99M	54.55M	83.98M	63.73M	80.51M
Revenue Growth	66.95%	29.84%	99.31%	-29.15%	53.95%	-24.11%	26.32%
EPS	-2.73	-3.71	-2.65	-2.88	-3.05	-3.11	-2.99
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	19	17

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	99.8M	233.7M
Avg	63.7M	80.5M
Low	49.0M	49.0M

Revenue Growth

Revenue Growth	2026	2027
High	18.8%	266.7%
Avg	-24.1%	26.3%
Low	-41.7%	-23.1%

EPS Forecast

EPS	2026	2027
High	-2.69	-2.17
Avg	-3.11	-2.99
Low	-3.64	-3.34

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.